# Purdue Pharma – FDA Inspection, Apr 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/purdue-pharma/e8217f26-6c57-472f-82cb-55f276da838b
Source feed: FDA_Inspections

> FDA inspection 1087591 of Purdue Pharma, April 26, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087591
- Company Name: Purdue Pharma
- Inspection Date: 2019-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1025638 - 2017-08-04
- FDA Inspection 938743 - 2015-07-10
- [FDA Inspection 852516 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/purdue-pharma/2cd4bbf9-a993-4692-aa87-b42d35c7bb54)
- FDA Inspection 734736 - 2011-07-15

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/carrie-a-hughes/099d1128-0ba9-4e7a-a0d2-8c10083811c9)

Company: https://www.keypedia.com/companies/purdue-pharma/9f005c9c-c52f-4830-b544-bd991a18cc7c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c